✦ LIBER ✦

Randomized Parallel Study of Doxorubicin Plus Paclitaxel and Doxorubicin Plus Cyclophosphamide as Neoadjuvant Treatment of Patients With Breast Cancer

✍ Scribed by Denlinger, C.S.; Goldstein, L.J.

Book ID: 123405327
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 57 KB
Volume: 16
Category: Article
ISSN: 1043-321X
DOI: 10.1016/S1043-321X(05)80223-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paclitaxel plus doxorubicin as first-lin

Paclitaxel plus doxorubicin as first-line treatment for breast cancer?

✍ Innes, Carmen 📂 Article 📅 1999 🏛 Adis International Limited (now part of Wolters Kl ⚖ 845 KB

Doxorubicin plus Ifosfamide as Salvage T

Doxorubicin plus Ifosfamide as Salvage Treatment for Patients with Advanced Breast Cancer Refractory to Epirubicin plus Cyclophosphamide

✍ Prof. Aristidis Polyzos, C. Kosmas, N. Tsavaris, C. Markopoulos, N. Kalahanis, O 📂 Article 📅 2000 🏛 Springer International Publishing AG 🌐 English ⚖ 175 KB

Phase III Trial Comparing Doxorubicin Pl

Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast Cancer

✍ Jones, S. E.; Savin, M. A.; Holmes, F. A.; O'Shaughnessy, J. A.; Blum, J. L.; Vu 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 372 KB

PCN50 COST-EFFECTIVENESS OF DOCETAXEL PL

PCN50 COST-EFFECTIVENESS OF DOCETAXEL PLUS CYCLOPHOSPHAMIDE VERSUS DOXORUBICIN PLUS CYCLOPHOSPHAMIDE IN THE ADJUVANT TREATMENT OF OPERABLE BREAST CANCER

✍ S Jones; L Chen; M Tangirala; L Asmar; P Airia; MF Thompson 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

PCN91 LONG TERM COST-EFFECTIVENESS OF DO

PCN91 LONG TERM COST-EFFECTIVENESS OF DOCETAXEL PLUS CYCLOPHOSPHAMIDE COMPARED TO DOXORUBICIN PLUS CYCLOPHOSPHAMIDE AS ADJUVANT TREATMENT FOR WOMEN WITH OPERABLE BREAST CANCER

✍ D Jackson; JM Lee; J Adams; A Gordois 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

A proof-of-principle study of epigenetic

A proof-of-principle study of epigenetic therapy with hydralazine and magnesium valproate plus doxorubicin cyclophosphamide as neoadjuvant therapy for locally advanced breast cancer

✍ Claudia Arce; Carlos Perez-Plasencia; Aurora Gonzalez-Fierro; Erik de la Cruz-He 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 165 KB